Search

everythinglearnresearchcommunity

for

Search:↓

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Analog 23 is a promising compound for prostate cancer treatment.

A new compound that could treat various androgen-related conditions was created and analyzed.

KRT85 gene variations can help improve wool traits in sheep through selective breeding.

A new compound was made that might help treat diseases related to male hormones.

Removing Sprouty genes in mice causes various hormone-related issues but does not increase cancer risk by one year of age.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

The April 2014 issue of "Fertility and Sterility" discussed various reproductive health topics, including hormone therapy benefits, sperm and genetic factors in male infertility, and the link between PCOS and diabetes.

A new antiandrogen compound was made and its detailed three-dimensional shape was described.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

A mother's western diet can make her milk toxic, causing inflammation and hair loss in babies.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

The combination of specific chemicals improves hair density in women.

Sweat duct differentiation in trichilemmal cysts is very rare and can be successfully removed with surgery.

Finasteride lowers risk of urinary issues and surgery by over 50% in 4 years.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

The compounds tested could potentially treat hair loss and alopecia.

The compound 4c showed strong potential as an anticancer agent.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

A patient with Ehlers-Danlos Syndrome improved after treatment for fat malabsorption and essential fatty acid deficiency.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Removing UBE2N from skin cells causes inflammation and immune response, which can be lessened with specific inhibitors.

The book is a detailed guide on facial cosmetic surgery techniques and advancements, useful for both trainees and specialists.